What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Internal medicine
The scientist’s investigation covers issues in Apoptosis, Biochemistry, Cell biology, Internal medicine and Programmed cell death.
He combines subjects such as Tumor necrosis factor alpha, Lipid raft and Resveratrol with his study of Apoptosis.
His studies deal with areas such as THP1 cell line, Oxysterol, Endothelium and Vitamin E as well as Cell biology.
As part of his studies on Internal medicine, Philippe Gambert frequently links adjacent subjects like Endocrinology.
His Programmed cell death research is multidisciplinary, relying on both Mitochondrion, Glutathione, Superoxide and Pharmacology.
His work deals with themes such as Cholesteryl ester, Very low-density lipoprotein, Lipoprotein and Chromatography, which intersect with Apolipoprotein B.
His most cited work include:
- Cisplatin-Induced CD95 Redistribution into Membrane Lipid Rafts of HT29 Human Colon Cancer Cells (268 citations)
- Resveratrol-induced Apoptosis Is Associated with Fas Redistribution in the Rafts and the Formation of a Death-inducing Signaling Complex in Colon Cancer Cells (245 citations)
- Glutathione is implied in the control of 7-ketocholesterol-induced apoptosis, which is associated with radical oxygen species production (199 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Endocrinology, Apolipoprotein B, Lipoprotein and Cholesterol.
Philippe Gambert works mostly in the field of Internal medicine, limiting it down to topics relating to Type 1 diabetes and, in certain cases, Autoimmune disease.
His Apolipoprotein B study combines topics from a wide range of disciplines, such as Enzyme, Low-density lipoprotein, High-density lipoprotein and Metabolism.
As a member of one scientific family, Philippe Gambert mostly works in the field of Lipoprotein, focusing on Chromatography and, on occasion, Gel electrophoresis.
His Cholesterol research incorporates elements of Endothelium and Vascular disease.
Cholesterylester transfer protein is a subfield of Biochemistry that he tackles.
He most often published in these fields:
- Internal medicine (57.14%)
- Endocrinology (50.65%)
- Apolipoprotein B (33.12%)
What were the highlights of his more recent work (between 2005-2013)?
- Internal medicine (57.14%)
- Endocrinology (50.65%)
- Cholesterol (30.52%)
In recent papers he was focusing on the following fields of study:
Philippe Gambert mostly deals with Internal medicine, Endocrinology, Cholesterol, Apolipoprotein B and Myocardial infarction.
Internal medicine is closely attributed to Type 1 diabetes in his research.
His work on Statin expands to the thematically related Endocrinology.
His work on Triglyceride, Very low-density lipoprotein and Apolipoprotein C as part of general Cholesterol study is frequently connected to Wild type, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
Philippe Gambert has included themes like High-density lipoprotein and Metabolism in his Apolipoprotein B study.
His research in Myocardial infarction intersects with topics in Natriuretic peptide, Cancer research, Surgery and Renal function.
Between 2005 and 2013, his most popular works were:
- Adiponectin Is an Important Determinant of ApoA-I Catabolism (119 citations)
- Multiplexed flow cytometric analyses of pro- and anti-inflammatory cytokines in the culture media of oxysterol-treated human monocytic cells and in the sera of atherosclerotic patients. (90 citations)
- Wine and oxidative stress: up-to-date evidence of the effects of moderate wine consumption on oxidative damage in humans. (89 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
Philippe Gambert mainly focuses on Internal medicine, Endocrinology, Biochemistry, Cholesterol and Apolipoprotein B.
His work on Myocardial infarction, Triglyceride, Vasodilation and Agonist as part of general Internal medicine research is frequently linked to Retinoic acid receptor alpha, bridging the gap between disciplines.
His Triglyceride research is multidisciplinary, incorporating perspectives in Abdominal obesity, Obese subjects and High-density lipoprotein.
His work in the fields of Biochemistry, such as Beta oxidation, Polyunsaturated fatty acid, Peroxisome and Adrenoleukodystrophy, overlaps with other areas such as Wild type.
His Cholesterol and Lipoprotein and Cholesterylester transfer protein investigations all form part of his Cholesterol research activities.
His Lipoprotein study integrates concerns from other disciplines, such as Adiponectin, Insulin resistance and Metabolic syndrome.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
